Vogt-Koyanagi-Harada Disease

References

• Moorthy RS, Inomata H, Rao NA. Vogt-Koyanagi-Harada syndrome. Surv Ophthalmol. 1995;39:265–292
   PubMed Web of Science ®Google Scholar
• Read RW, Rao NA, Cunningham ET Jr. Vogt-Koyanagi-Harada disease. Curr Opin Ophthalmol. 2000;11:437–442
   PubMedGoogle Scholar
• Damico FM, Kiss S, Young LH. Vogt-Koyanagi-Harada disease. Semin Ophthalmol. 2005;20:183–190
   PubMedGoogle Scholar
• Fang W, Yang P. Vogt-koyanagi-harada syndrome. Curr Eye Res. 2008;33:517–523
   PubMed Web of Science ®Google Scholar
• Jap A, Chee SP. Imaging in the diagnosis and management of Vogt-Koyanagi-Harada disease. Int Ophthalmol Clin. 2012;52:163–172
   PubMedGoogle Scholar
• Sakata VM, da Silva FT, Hirata CE, et al. Diagnosis and classification of Vogt-Koyanagi-Harada disease. Autoimmun Rev. 2014;13:550–555
   PubMed Web of Science ®Google Scholar
• Read RW, Holland GN, Rao NA, et al. Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature. Am J Ophthalmol. 2001;131:647–652
   PubMed Web of Science ®Google Scholar
• Yamaki K, Hara K, Sakuragi S. Application of revised diagnostic criteria for vogt-koyanagi-harada disease in Japanese patients. Jpn J Ophthalmol. 2005;49:143–148
   PubMed Web of Science ®Google Scholar
• Tugal-Tutkun I, Ozyazgan Y, Akova YA, et al. The spectrum of Vogt-Koyanagi-Harada disease in Turkey: VKH in Turkey. Int Ophthalmol. 2007;27:117–123
   PubMedGoogle Scholar
• Khairallah M, Zaouali S, Messaoud R, et al. The spectrum of Vogt-Koyanagi-Harada disease in Tunisia, North Africa. Int Ophthalmol. 2007;27:125–130
   Google Scholar
• Rao NA, Sukavatcharin S, Tsai JH. Vogt-Koyanagi-Harada disease diagnostic criteria. Int Ophthalmol. 2007;27:195–199
   PubMedGoogle Scholar
• Yodmuang T, Rothova A, Kunavisarut P, Pathanapitoon K. Vogt-Koyanagi-Harada disease in Thailand. Ocul Immunol Inflamm. 2012;20:419–422
   PubMed Web of Science ®Google Scholar
• Rao NA, Gupta A, Dustin L, et al. Frequency of distinguishing clinical features in Vogt-Koyanagi-Harada disease. Ophthalmology. 2010;117:591–599
   PubMed Web of Science ®Google Scholar
• Yang P, Ren Y, Li B, et al. Clinical characteristics of Vogt-Koyanagi-Harada syndrome in Chinese patients. Ophthalmology. 2007;114:606–614
   PubMed Web of Science ®Google Scholar
• Roe RH, Rathinam SR, Wong RW, et al. Delayed fellow eye involvement in patients with Vogt-Koyanagi-Harada disease. Br J Ophthalmol. 2009;93:701–702
   PubMed Web of Science ®Google Scholar
• Paredes I, Ahmed M, Foster CS. Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy. Ocul Immunol Inflamm. 2006;14:87–90
   PubMed Web of Science ®Google Scholar
• Kim SJ, Yu HG. The use of low-dose azathioprine in patients with Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2007;15:381–387
   PubMed Web of Science ®Google Scholar
• Cuchacovich M, Solanes F, Díaz G, et al. Comparison of the clinical efficacy of two different immunosuppressive regimens in patients with chronic vogt-koyanagi-harada disease. Ocul Immunol Inflamm. 2010;18:200–207
   PubMed Web of Science ®Google Scholar
• Abu El-Asrar AM, Hemachandran S, Al-Mezaine HS, et al. The outcomes of mycophenolate mofetil therapy combined with systemic corticosteroids in acute uveitis associated with Vogt-Koyanagi-Harada disease. Acta Ophthalmol. 2012;90:e603–e608
   PubMedGoogle Scholar
• Abu El-Asrar AM, Al Tamimi M, Hemachandran S, et al. Prognostic factors for clinical outcomes in patients with Vogt-Koyanagi-Harada disease treated with high-dose corticosteroids. Acta Ophthalmol. 2013;91:e486–e493
   PubMed Web of Science ®Google Scholar
• Kawaguchi T, Horie S, Bouchenaki N, et al. Suboptimal therapy controls clinically apparent disease but not subclinical progression of Vogt-Koyanagi-Harada disease. Int Ophthalmol. 2010;30:41–50
   PubMedGoogle Scholar
• da Silva FT, Hirata CE, Sakata VM, et al. Indocyanine green angiography findings in patients with long-standing Vogt-Koyanagi-Harada disease: a cross-sectional study. BMC Ophthalmol. 2012;12:40
   PubMed Web of Science ®Google Scholar
• Ozdal P, Ozdamar Y, Yazici A, et al. Vogt-Koyanagi-Harada disease: Clinical and demographic characteristics of patients in a specialized eye hospital in Turkey. Ocul Immunol Inflamm. 2014;22:277–286
   Google Scholar
• Xu M, Wang C, Tian Y, et al. Inhibition of proinflammatory cytokine by IL-25 in Vogt-Koyangi-Harada Syndrome. Ocul Immunol Inflamm. 2014;22:294–299
   Google Scholar
• Rani PK, Chandra P. Typical smokestack leak sign in a case of Vogt-Koyanagi-Harada disease. Ocul Immunol Inflamm. 2014;22:341–344
   Google Scholar
• Garza Leon M, Herrera-Jimenez IP, Gonzalez-Madrigal PM. Complete Vogt-Koyangi-Harada disease and Holmes-Adie syndrome: Case report. Ocul I Ocul Immunol Inflamm. 2014;22:336–340
   Google Scholar
• Tanigawa M, Ochiai H, Tsukahara Y, et al. Choroidal folds in acute-stage Vogt-Koyanagi-Harada disease patients with relatively short axial length. Case Rep Ophthalmol. 2012;3:38–45
   PubMedGoogle Scholar
• Kato Y, Yamamoto Y, Tabuchi H, Fukushima A. Retinal pigment epithelium folds as a diagnostic finding of Vogt-Koyanagi-Harada disease. Jpn J Ophthalmol. 2013;57:90–94
   PubMed Web of Science ®Google Scholar
• Hosoda Y, Uji A, Hangai M, Morooka S, et al. Relationship between retinal lesions and inward choroidal bulging in Vogt-Koyanagi-Harada disease. Am J Ophthalmol. 2014;157:1056–1063
   PubMed Web of Science ®Google Scholar
• Sakata VM, da Silva FT, Hirata CE, et al. Choroidal bulging in patients with Vogt-Koyanagi-Harada disease in the non-acute uveitic stage. J Ophthalmic Inflamm Infect. 2014;4:6 . doi: 10.1186/1869-5760-4-6
   PubMedGoogle Scholar
• Schalenbourg A1, Leys A, De Courten C, et al. Corticosteroid-induced central serous chorioretinopathy in patients with ocular inflammatory disorders. Klin Monbl Augenheilkd. 2002;219:264–267
   PubMed Web of Science ®Google Scholar
• Khairallah M, Kahloun R, Tugal-Tutkun I. Central serous chorioretinopathy, corticosteroids, and uveitis. Ocul Immunol Inflamm. 2012;20:76–85
   PubMed Web of Science ®Google Scholar
• Arantes TE, Garcia CR, Rossi MR, Muccioli C. Spectral domain optical coherence tomography and angiographic findings in central serous chorioretinopathy complicated by bilateral nonrhegmatogenous retinal detachment associated with systemic corticosteroids. Ocul Immunol Inflamm. 2009;17:316–318
   PubMed Web of Science ®Google Scholar
• Brouzas D, Chatzoulis D, Galina E, et al. Corneal anesthesia in a case with Vogt-Koyanagi-Harada syndrome. Acta Ophthalmol Scand. 1997;75:464–465
   PubMedGoogle Scholar
• Kim JS, Yun CH, Moon CS. Bilateral tonic (Adie’s) pupils in Vogt-Koyanagi-Harada syndrome. J Neuro-Ophthalmol. 2001;21:205–206
   PubMed Web of Science ®Google Scholar
• Narang S, Sood S, Malik A. Probable Vogt-Koyanagi-Harada’s syndrome assoicated with tonic pupils. Nepal J Ophthalmol. 2010;2:154–156
   PubMedGoogle Scholar